
Overview
Dospiro is a strategic partner in pharmaceutical distribution and part of the Pelion S.A. group. It provides manufacturers, wholesalers and pharmacies with warehousing, transport, marketing, sales and distribution services for specialized medicinal products, and supports commercial and non-commercial clinical trials. Its warehouses enable controlled storage at 2–8°C and 15–25°C in line with Good Distribution Practice requirements.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $216,873 |
Filing timeliness
Financial statements were filed on time, on average 25 days early. 1 of 4 audited by a statutory auditor.
- 202530/06/2026
- 202427/06/2025
- 202323/06/2024
- 202230/05/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Medicinal product warehousing
- Medicine distribution
- Pharmaceutical transport
- Clinical trial management
- Clinical trial medicine supply
Websites
- dospiro.plDOSPIRO Sp. z o.o.Apache
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2023.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| DOSPIRO | Z.580248 | 5, 35, 39 | Protected | Feb 11, 2035 | |
| DOSPIRO | Z.554813 | 5, 35, 39 | Refused | – |
| Mark | Protected until | |
|---|---|---|
| DOSPIRO | Feb 11, 2035 | |
| DOSPIRO | – |
Authorized Representatives
Manner of representation
The submission of declarations of will on behalf of the company requires the joint action of two members of the management board or a member of the management board together with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 134,670 | $3,637,763.37 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-01-25.
60 1600 0003 1713 0795 6000 0001
92 1600 0003 1713 0795 6000 0007
06 1600 0003 1713 0795 6000 0003
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 23,816PLN 23,816 |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Komtur Polska sp. z o.o. | $424,362,396.43 | komtur.pl | ||
| Organizacja Polskich Dystrybutorów Farmaceutycznych S.A. | $263,782,982.61 | opdf.com.pl | ||
| Producencka Centrala Farmaceutyczna Procefar sp. z o.o. | $140,213,508.12 | procefar.pl | ||
| Phoenix Pharma Polska sp. z o.o. | $140,768,509.34 | phoenixpharma.pl | ||
| Medezin sp. z o.o. | $107,559,392.19 | medezin.pl | ||
| Pelion S.A. | $99,756,667.36 | pelion.eu | ||
| Modumpharma sp. z o.o. | $89,444,792.63 | modumpharma.com | ||
| Cefarm Białystok S.A. | $50,062,782.52 | farmacol.com.pl | ||
| Lek4you sp. z o.o. | $31,600,043.42 | lek4you.pl | ||
| Medyk-Lek Panek sp. z o.o. sp. k. | $20,167,374.20 | medyklek.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-09-17 | Share capital increase (5,000.00 PLN → 13,467,000.00 PLN) | |
| 2023-01-04 | PKD change (Removed: 6 codes; Added: 7 codes) | |
| 2022-11-16 | Address change (Ul. Pojezierska 90a, 91-341, Łódź → Ul. Zbąszyńska 3, 91-342, Łódź) | |
| 2022-03-08 | Name change (Business 21 Spółka Z Ogranczoną Odpowiedzialnością → Dospiro) | |
| 2021-12-09 | Entered in the register |
FAQ
Last updated: 2026-10-07